Patient-Reported Outcomes With Etoricoxib in Real Life.

Trial Profile

Patient-Reported Outcomes With Etoricoxib in Real Life.

Phase of Trial: Phase IV

Latest Information Update: 19 Jun 2014

At a glance

  • Drugs Etoricoxib (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 16 Oct 2009 Status changed from active, no longer recruiting to completed as reported by
    • 04 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top